N-[5-bromo-2-hydroxy-1-(2-phenylethyl)indol-3-yl]imino-2,3-dihydrobenzo[g][1,4]benzodioxine-3-carboxamide
C29H22BrN3O4 — CID 135571514
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[5-bromo-2-hydroxy-1-(2-phenylethyl)indol-3-yl]imino-2,3-dihydrobenzo[g][1,4]benzodioxine-3-carboxamide
N-[5-bromo-2-hydroxy-1-(2-phenylethyl)indol-3-yl]imino-2,3-dihydrobenzo[g][1,4]benzodioxine-3-carboxamide (PubChem CID 135571514) has the molecular formula C29H22BrN3O4 and a molecular weight of 556.42 g/mol. Its IUPAC name is N-[5-bromo-2-hydroxy-1-(2-phenylethyl)indol-3-yl]imino-2,3-dihydrobenzo[g][1,4]benzodioxine-3-carboxamide.
Molecular Properties
| Compound Name | N-[5-bromo-2-hydroxy-1-(2-phenylethyl)indol-3-yl]imino-2,3-dihydrobenzo[g][1,4]benzodioxine-3-carboxamide |
|---|---|
| PubChem CID | 135571514 |
| Molecular Formula | C29H22BrN3O4 |
| Molecular Weight | 556.42 g/mol |
| Exact Mass | 555.08 |
| IUPAC Name | N-[5-bromo-2-hydroxy-1-(2-phenylethyl)indol-3-yl]imino-2,3-dihydrobenzo[g][1,4]benzodioxine-3-carboxamide |
| SMILES | O=C(/N=N/c1c(O)n(CCc2ccccc2)c2ccc(Br)cc12)C1COc2cc3ccccc3cc2O1 |
| InChI | InChI=1S/C29H22BrN3O4/c30-21-10-11-23-22(16-21)27(29(35)33(23)13-12-18-6-2-1-3-7-18)31-32-28(34)26-17-36-24-14-19-8-4-5-9-20(19)15-25(24)37-26/h1-11,14-16,26,35H,12-13,17H2/b32-31+ |
| InChIKey | JUNDSLGRFCMJLH-QNEJGDQOSA-N |
| XLogP | 6.96 |
| TPSA | 85.41 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 37 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 556.42 |
| LogP ≤ 5 | 6.96 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 6 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'azo_A(324)', 'substructure': 'N/A'}, {'alert_name': 'diazo_group', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 135571514 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.